منابع مشابه
Pharmacologic neuroprotection: the search continues.
Dozens of drugs have been studied in an attempt to mitigate the adverse cerebral consequences of cardiac surgery. The targets for these drugs have focused on pathways identified through the cascade of events that occurs once cerebral ischemia is initiated. In addition, inflammatory targets specific to cardiopulmonary bypass have also been addressed. Although no drugs are yet approved as specifi...
متن کاملBiomarkers for bladder cancer: The search continues!
Cystoscopy has remained the gold standard for the detection of bladder cancer for decades. Although many new fancy molecular markers have been developed and are widely applied in the diagnosis and management of various cancers today, no single marker has dethroned cystoscopy as " the tool " in the detection of bladder cancer. Although advances in technology have provided fluorescence and narrow...
متن کاملA replacement for warfarin: the search continues.
Vitamin K antagonists (VKAs) such as warfarin are the only oral anticoagulants currently available for clinical use. Warfarin has numerous limitations, including slow onset and offset of action, a narrow therapeutic window, and a metabolism that is affected by diet, drugs, and genetic polymorphisms.1 Because of its unpredictable dose response, warfarin requires careful coagulation monitoring to...
متن کاملTargeting Myocardial Reperfusion Injury--The Search Continues.
Timely reperfusion by means of primary percu taneous coronary intervention (PCI) is the most effective therapy for limiting myocardial infarct size in patients with STsegment elevation myo cardial infarction (STEMI). Although mortality in this patient population is falling, the number of patients in whom heart failure develops is increasing. As such, new treatments are needed to reduce myoca...
متن کاملBiomarkers in COPD: the search continues!
In a working group of the National Institutes of Health focusing on biomarkers and surrogate end-points, a biomarker was defined as a “characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention” [1]. In the same document, the National Institutes of Health defined a clinica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New Scientist
سال: 2020
ISSN: 0262-4079
DOI: 10.1016/s0262-4079(20)30612-6